cas 2573776-84-6|| where to buy methyl 1-(3-bromophenyl)-3-methylcyclobutane-1-carboxylate

Produktname:methyl 1-(3-bromophenyl)-3-methylcyclobutane-1-carboxylate

IUPAC Name:methyl 1-(3-bromophenyl)-3-methylcyclobutane-1-carboxylate

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2573776-84-6 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:2573776-84-6; Molekulare Formel:C13H15BrO2; Schmelzpunkt:-; SMILES-Code:O=C(OC)C1(C=2C=CC=C(Br)C2)CC(C)C1; Dichte:

: Katalognummer:CM1075490; Molekulargewicht:283.17; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

: NX-1607; Nurix disclosed the discovery and structure of NX-1607 in the First Time Disclosures session at the American Chemical Society Spring 2024 meeting in New Orleans, LA. This is the first inhibitor of CBL-B to advance into clinical studies and a prime example of Nurix’s ability to target previously undruggable E3 ligases.